List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 367 studies with search of: glioma | Open Studies
Include studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting A Study of Bevacizumab Therapy in Patients With Newly Diagnosed High-Grade Gliomas and Diffuse Intrinsic Pontine Gliomas
Conditions: Newly Diagnosed High-Grade Gliomas;   Diffuse Intrinsic Pontine Glioma
Interventions: Drug: Temozolomide;   Drug: Bevacizumab;   Drug: Irinotecan
2 Recruiting Identification of Clinically Occult Glioma Cells and Characterization of Glioma Behavior Through Machine Learning Analysis of Advanced Imaging Technology
Condition: Glioma
Interventions: Procedure: MRS Imaging;   Procedure: PET Scanning;   Procedure: Difussion Tensor Imaging
3 Recruiting An Open Label Dose Escalation Safety Study of Convection-Enhanced Delivery of IL13-PE38QQR in Patients With Progressive Pediatric Diffuse Infiltrating Brainstem Glioma and Supratentorial High-grade Glioma
Conditions: Brain Neoplasm;   Glioma
Intervention: Drug: IL13-PE38QQR
4 Recruiting Vaccine Therapy in Treating Young Patients With Newly Diagnosed or Recurrent Glioma
Condition: Brain and Central Nervous System Tumors
Interventions: Biological: HLA-A2-restricted synthetic glioma antigen peptides vaccine;   Drug: poly ICLC;   Genetic: reverse transcriptase-polymerase chain reaction;   Other: enzyme-linked immunosorbent assay;   Other: flow cytometry;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis
5 Recruiting A Study of XL765 in Combination With Temozolomide in Adults With Malignant Gliomas
Conditions: Mixed Gliomas;   Malignant Gliomas;   Glioblastoma Multiforme
Interventions: Drug: XL765;   Drug: Temozolomide
6 Recruiting Bevacizumab and Irinotecan in Treating Young Patients With Recurrent, Progressive, or Refractory Glioma, Medulloblastoma, Ependymoma, or Low Grade Glioma
Condition: Brain and Central Nervous System Tumors
Interventions: Biological: bevacizumab;   Drug: irinotecan hydrochloride;   Procedure: magnetic resonance imaging;   Procedure: positron emission tomography;   Radiation: fludeoxyglucose F 18
7 Recruiting Vaccine Therapy in Treating Patients With Malignant Glioma
Condition: Brain and Central Nervous System Tumors
Intervention: Biological: glioma-associated antigen peptide-pulsed autologous dendritic cell vaccine
8 Recruiting Correlation Between SV2A Expression in Tumour Tissue and Efficacy of Levetiracetam in Glioma Patients With Epilepsy
Conditions: Epilepsy;   Glioma
Intervention:
9 Recruiting Sorafenib in Newly Diagnosed High Grade Glioma
Conditions: High Grade Glioma;   Glioblastoma;   Gliosarcoma;   Anaplastic Astrocytoma;   Anaplastic Oligoastrocytoma;   Anaplastic Oligodendroglioma
Intervention: Drug: Sorafenib dose escalation
10 Recruiting Capecitabine and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Nonmetastatic Brain Stem Glioma or High-Grade Glioma
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: capecitabine;   Other: pharmacological study;   Procedure: adjuvant therapy;   Procedure: magnetic resonance imaging;   Procedure: magnetic resonance spectroscopic imaging;   Radiation: radiation therapy
11 Recruiting Biobank Glioma: Storing Blood for Analysis of DNA and Protein of Patients With Glioma
Condition: Glioma
Intervention:
12 Recruiting Vaccination With Lethally Irradiated Glioma Cells Mixed With GM-K562 Cells in Patients Undergoing Craniotomy For Recurrent Tumor
Condition: Glioma
Intervention: Biological: GM-K562 Vaccination
13 Recruiting Pharmacokinetics (PK) Study of AC480 for Recurrent Glioma
Condition: Glioma
Intervention: Drug: AC480
14 Not yet recruiting Valproic Acid and Radiation Followed by Maintenance Valproic Acid and Bevacizumab in Children With High Grade Gliomas
Conditions: Glial Cell Tumors;   Malignant Gliomas
Interventions: Drug: Valproic acid;   Drug: Bevacizumab;   Radiation: Radiation therapy
15 Not yet recruiting Hypertension Monitoring in Glioma Patients Treated With Bevacizumab
Condition: Glioma
Intervention:
16 Recruiting Phase II Trial of RAD001 in Patients With Recurrent Low Grade Glioma
Conditions: Low-grade Glioma;   Astrocytoma;   Oligodendroglioma;   Mixed Oligoastrocytoma
Intervention: Drug: RAD001
17 Recruiting Late Effects of Proton Radiation Therapy in Patients With Low-Grade Glioma
Condition: Low Grade Gliomas
Intervention: Radiation: Proton Radiation Therapy
18 Recruiting Genetic Analysis of Brain Tumors
Condition: Glioma
Intervention:
19 Not yet recruiting Panitumumab and Irinotecan for Malignant Gliomas
Condition: Recurrent Grade IV Malignant Glioma
Intervention: Drug: Panitumumab in Combination with Irinotecan
20 Recruiting Coping With High Grade Glioma
Condition: Glioma
Interventions: Behavioral: coping skills intervention training;   Behavioral: usual care

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services